https://aeratx.com/press-releases/ 2026-09-01T12:26:29+00:00 https://aeratx.com/aera-therapeutics-launches-with-193-million-in-financing-to-enable-and-advance-the-next-generation-of-transformative-genetic-medicines/ 2023-02-16T05:23:30+00:00 https://aeratx.com/aera-therapeutics-appoints-paul-conrad-ph-d-mba-as-chief-business-and-financial-officer/ 2025-05-12T11:49:14+00:00 https://aeratx.com/aera-therapeutics-appoints-bill-querbes-ph-d-as-chief-scientific-officer/ 2025-09-02T11:14:21+00:00 https://aeratx.com/aera-therapeutics-presents-preclinical-data-and-announces-nomination-of-first-development-candidate-aera-109-a-targeted-in-vivo-car-t-therapy-for-b-cell-mediated-autoimmune-diseases/ 2025-09-24T10:30:49+00:00 https://aeratx.com/aera-therapeutics-announces-participation-in-upcoming-investor-conferences/ 2025-11-05T12:47:39+00:00 https://aeratx.com/aera-therapeutics-to-present-preclinical-data-on-aera-109-a-targeted-in-vivo-car-t-therapy-for-b-cell-mediated-autoimmune-diseases-at-the-67th-american-society-of-hematology-ash-annual-meeting/ 2025-12-02T15:24:16+00:00 https://aeratx.com/aera-therapeutics-to-present-at-upcoming-investor-conferences/ 2026-09-01T12:26:29+00:00